HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
 Help
INSM [NASD]
Insmed Incorporated
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-3.78 Insider Own1.10% Shs Outstand118.93M Perf Week10.80%
Market Cap2.49B Forward P/E- EPS next Y-3.10 Insider Trans-9.33% Shs Float116.58M Perf Month12.95%
Income-437.60M PEG- EPS next Q-0.89 Inst Own- Short Float9.81% Perf Quarter-11.30%
Sales201.40M P/S12.36 EPS this Y-28.70% Inst Trans3.46% Short Ratio9.95 Perf Half Y-21.58%
Book/sh1.01 P/B21.84 EPS next Y12.20% ROA-35.40% Target Price49.44 Perf Year-21.38%
Cash/sh5.63 P/C3.92 EPS next 5Y- ROE-111.80% 52W Range16.41 - 34.44 Perf YTD-19.02%
Dividend- P/FCF- EPS past 5Y-6.40% ROI-39.40% 52W High-34.05% Beta1.96
Dividend %- Quick Ratio5.50 Sales past 5Y- Gross Margin76.90% 52W Low38.39% ATR1.14
Employees613 Current Ratio6.00 Sales Q/Q32.10% Oper. Margin- RSI (14)64.39 Volatility5.22% 5.53%
OptionableYes Debt/Eq6.73 EPS Q/Q10.50% Profit Margin- Rel Volume0.29 Prev Close22.06
ShortableYes LT Debt/Eq6.73 EarningsMay 05 BMO Payout- Avg Volume1.15M Price22.71
Recom1.80 SMA2016.24% SMA5014.18% SMA200-6.84% Volume23,532 Change2.95%
Apr-27-22Initiated Goldman Buy $56
Dec-06-21Initiated JP Morgan Overweight $45
Oct-19-21Resumed Morgan Stanley Overweight $56 → $52
Oct-19-21Resumed Monness Crespi & Hardt Buy $52
Oct-08-21Initiated Cantor Fitzgerald Overweight $60
Apr-26-21Resumed Credit Suisse Outperform $60
Dec-17-20Initiated Berenberg Buy $48
Oct-12-20Resumed Stifel Buy $44
Sep-03-19Initiated Goldman Buy $30
Apr-09-19Reiterated H.C. Wainwright Buy $43 → $52
Feb-15-19Upgrade JMP Securities Mkt Perform → Mkt Outperform $40
Jan-17-19Upgrade Goldman Neutral → Buy
Jan-02-19Initiated Canaccord Genuity Buy $20
Aug-06-18Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jul-23-18Initiated Goldman Neutral $32
Apr-23-18Upgrade Credit Suisse Neutral → Outperform
Mar-21-18Initiated Morgan Stanley Overweight $39
Jan-18-18Initiated Credit Suisse Neutral $31
Sep-05-17Reiterated Evercore ISI Outperform $28 → $40
Aug-17-17Initiated Evercore ISI Outperform $28
Jun-09-22 09:42AM  
10 Stocks Under $30 to Buy Today According to Billionaire Steven Cohen
Insider Monkey
Jun-03-22 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire +5.91%
May-23-22 08:00AM  
Insmed Names Drayton Wise Chief Commercial Officer
PR Newswire
May-17-22 06:05PM  
Insmed Presents New Data Across Three Pillars at American Thoracic Society 2022 International Conference
PR Newswire +9.14%
08:00AM  
Insmed To Present at the H.C. Wainwright Annual Global Life Sciences Conference
PR Newswire
May-15-22 08:52AM  
Trade Alert: The Independent Director Of Insmed Incorporated (NASDAQ:INSM), Melvin Sharoky, Has Just Spent US$344k Buying 8.7% More Shares
Simply Wall St.
May-06-22 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire -10.48%
May-05-22 09:05AM  
Insmed (INSM) Reports Q1 Loss, Misses Revenue Estimates
Zacks
07:30AM  
Insmed Reports First Quarter 2022 Financial Results and Provides Business Update
PR Newswire
May-04-22 09:10PM  
Goldman Sachs Sees These 2 Strong Buy Stocks Skyrocketing Over 70%
TipRanks
Apr-28-22 03:02PM  
Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks
Apr-21-22 08:00AM  
Insmed to Host First Quarter 2022 Financial Results Conference Call on Thursday, May 5, 2022
PR Newswire -5.59%
Apr-07-22 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Mar-28-22 08:00AM  
Insmed to Showcase New Data Across Three Pillars at the American Thoracic Society 2022 International Conference
PR Newswire
Mar-04-22 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Mar-03-22 08:00AM  
Insmed To Present at the Cowen 42nd Annual Health Care Conference
PR Newswire
Feb-17-22 08:25AM  
Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates
Zacks
07:00AM  
Insmed Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business and Pipeline Update
PR Newswire
Feb-10-22 03:01PM  
Insmed (INSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks
08:00AM  
Insmed To Present at the SVB Leerink Virtual 11th Annual Global Healthcare Conference
PR Newswire
Feb-04-22 04:05PM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Jan-27-22 08:00AM  
Insmed to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Provide a Business and Pipeline Update on Thursday, February 17, 2022
PR Newswire
Jan-08-22 08:52AM  
Investors might be losing patience for Insmed's (NASDAQ:INSM) increasing losses, as stock sheds 5.5% over the past week
Simply Wall St.
Jan-04-22 08:00AM  
Insmed To Present at the 40th Annual J.P. Morgan Healthcare Conference
PR Newswire
Dec-29-21 12:20PM  
Insmed Inc Insiders are Selling. Investors Should Take Notice
GuruFocus.com
Dec-07-21 12:53PM  
10 Pharmaceutical Stocks to Buy According to Brandon Haleys Holocene Advisors
Insider Monkey
Dec-06-21 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Nov-29-21 11:32AM  
10 Biotech and Pharma Stocks to Buy According to Billionaire Steve Cohen
Insider Monkey -6.26%
Nov-15-21 10:43AM  
Morgan Stanley: These 3 Strong Buy Stocks Could Surge at Least 60%
TipRanks
Nov-09-21 08:34AM  
Bullish Insmed Incorporated (NASDAQ:INSM) insiders were rewarded last week as their US$831k investment inflated to US$885k
Simply Wall St.
Nov-05-21 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Nov-03-21 08:00AM  
Insmed To Participate in Three November Conferences
PR Newswire
Oct-29-21 05:30PM  
Insmed Inc (INSM) Q3 2021 Earnings Call Transcript
Motley Fool
09:27AM  
New Strong Sell Stocks for October 29th
Zacks
Oct-28-21 04:05PM  
Insmed Ranks No. 1 on Science's 2021 Top Biopharma Employers List
PR Newswire +12.08%
08:45AM  
Insmed (INSM) Reports Q3 Loss, Lags Revenue Estimates
Zacks
07:30AM  
Insmed Reports Third Quarter 2021 Financial Results and Provides Business Update
PR Newswire
Oct-25-21 12:46PM  
Where Do Hedge Funds Stand On Insmed Incorporated (INSM)?
Insider Monkey
Oct-21-21 03:02PM  
Analysts Estimate Insmed (INSM) to Report a Decline in Earnings: What to Look Out for
Zacks
Oct-14-21 08:00AM  
Insmed to Host Third Quarter 2021 Financial Results Conference Call on Thursday, October 28, 2021
PR Newswire -6.69%
Oct-05-21 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Sep-10-21 09:18AM  
An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 36% Undervalued
Simply Wall St.
Sep-09-21 07:13PM  
Chief Compliance Officer Of Insmed Trades $730.57 Thousand In Company Stock
Benzinga
Sep-03-21 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Sep-01-21 08:00AM  
Insmed To Participate in Five September Conferences
PR Newswire
Aug-06-21 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
07:23AM  
Insmed (INSM) Sees Hammer Chart Pattern: Time to Buy?
Zacks
Aug-05-21 09:05AM  
Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
Zacks
07:30AM  
Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update
PR Newswire
Jul-29-21 03:05PM  
Earnings Preview: Insmed (INSM) Q2 Earnings Expected to Decline
Zacks
Jul-27-21 10:00AM  
Here's Why Insmed (INSM) is Poised for a Turnaround After Losing 19.5% in 4 Weeks
Zacks
08:00AM  
Insmed to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021
PR Newswire
Jul-19-21 12:08PM  
Where Do Hedge Funds Stand On Insmed Incorporated (INSM)?
Insider Monkey
Jul-08-21 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Jun-04-21 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
May-25-21 07:00AM  
Insmed To Present at Two June Conferences
PR Newswire
May-19-21 04:05PM  
Insmed Presents Broad Range of Data Across Its Three Programs at the American Thoracic Society 2021 International Conference
PR Newswire
May-13-21 11:14AM  
Insmed Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes and Full Exercise of Underwriters' Options to Purchase Additional Shares and Notes
PR Newswire
May-11-21 01:54AM  
Insmed Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028
PR Newswire
May-10-21 07:00AM  
Insmed Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028
PR Newswire -20.23%
May-07-21 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
May-06-21 09:05AM  
Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates
Zacks +6.49%
07:30AM  
Insmed Reports First Quarter 2021 Financial Results and Provides Business Update
PR Newswire
01:48AM  
Here's Why We Think Insmed Incorporated's (NASDAQ:INSM) CEO Compensation Looks Fair for the time being
Simply Wall St.
May-02-21 05:22AM  
Investors Who Bought Insmed (NASDAQ:INSM) Shares Five Years Ago Are Now Up 204%
Simply Wall St.
Apr-29-21 05:03PM  
Analysts Estimate Insmed (INSM) to Report a Decline in Earnings: What to Look Out for
Zacks
Apr-22-21 11:00PM  
Is INSM Stock A Buy or Sell?
Insider Monkey
12:33PM  
Earnings Preview: Insmed (INSM) Q1 Earnings Expected to Decline
Zacks
08:00AM  
Insmed to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 6, 2021
PR Newswire
Apr-07-21 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Mar-23-21 05:00AM  
ARIKAYCE® (amikacin liposome inhalation suspension) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients with NTM Lung Disease Caused by MAC Who Did Not Sufficiently Respond to Prior Treatment with MDR
PR Newswire -6.38%
Mar-05-21 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Feb-25-21 07:30AM  
Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
PR Newswire -7.17%
06:30AM  
Insmed, Inc. to Host Earnings Call
ACCESSWIRE
Feb-24-21 08:00AM  
Insmed to Present at Two March Conferences
PR Newswire
Feb-19-21 08:37AM  
Insmed's Inhaled Treprostinil Palmitil Is Safe; Healthy Volunteers Study Show
Benzinga
07:30AM  
Insmed Announces Topline Results from Phase 1 Study of Treprostinil Palmitil Inhalation Powder (TPIP)
PR Newswire
Feb-16-21 08:00AM  
Insmed to Host Conference Call to Discuss Topline Data from Treprostinil Palmitil Inhalation Powder Phase 1 Study
PR Newswire
Feb-12-21 08:00AM  
Insmed to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021
PR Newswire
Jan-31-21 03:45AM  
Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?
Simply Wall St.
Jan-22-21 03:08AM  
Is OSI Systems, Inc.'s(NASDAQ:OSIS) Recent Stock Performance Tethered To Its Strong Fundamentals?
Simply Wall St.
Jan-19-21 09:54AM  
OSI Systems Announces Second Quarter Conference Call
Business Wire +8.83%
Jan-05-21 08:00AM  
Insmed to Present at the 39th Annual J.P. Morgan Healthcare Conference
PR Newswire
Jan-04-21 08:00AM  
Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with MAC Lung Disease
PR Newswire
Dec-29-20 08:30AM  
OSI Systems Receives $10 Million Contract for Mobile Cargo and Vehicle Inspection Systems
Business Wire
Dec-23-20 02:59AM  
Does OSI Systems' (NASDAQ:OSIS) CEO Salary Compare Well With Industry Peers?
Simply Wall St.
Dec-22-20 08:30AM  
OSI Systems Receives $13 Million in Orders for Airport Screening Products
Business Wire
Dec-16-20 09:18AM  
Is OSIS A Good Stock To Buy Now?
Insider Monkey -10.04%
08:30AM  
OSI Systems Receives $12 Million Order for Cargo and Vehicle Inspection Systems
Business Wire
Dec-15-20 08:30AM  
OSI Systems Receives $6 Million Order for Smart Lighting Controllers
Business Wire
Dec-14-20 09:59AM  
OSI Systems Receives $39 Million International Order to Provide Cargo and Vehicle Inspection Systems
Business Wire
Dec-04-20 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Dec-03-20 08:50AM  
Insmed (INSM) Starts Dosing in Phase III Bronchiectasis Study
Zacks
Dec-02-20 08:00AM  
Insmed Announces Initiation of Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis
PR Newswire
Nov-29-20 06:44AM  
Top 10 Healthcare Stocks To Buy for the Future
Insider Monkey
Nov-24-20 08:00AM  
Insmed to Present at the Evercore ISI 3rd Annual HealthCONx Conference
PR Newswire
Nov-13-20 08:00AM  
Insmed Receives Priority Medicines (PRIME) Designation from European Medicines Agency (EMA) for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)
PR Newswire
Nov-06-20 08:00AM  
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire
Nov-02-20 08:00AM  
Insmed to Present at Two November Conferences
PR Newswire
05:29AM  
Insmed Incorporated (NASDAQ:INSM) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Simply Wall St.
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Michael AlexanderGeneral Counsel, Senior VPMay 17Sale20.371,05521,49050,583May 18 04:07 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerMay 17Sale20.271,67033,85168,822May 18 04:07 PM
Lewis WilliamChair and CEOMay 17Sale20.185,996120,999255,828May 18 04:07 PM
Adsett RogerChief Operating OfficerMay 17Sale20.342,02241,127145,982May 18 04:10 PM
Adsett RogerChief Operating OfficerMay 16Sale18.451,39425,719148,004May 18 04:10 PM
Lewis WilliamChair and CEOMay 16Sale18.353,39862,353261,824May 18 04:07 PM
Bonstein SaraChief Financial OfficerMay 16Sale18.511,43326,52554,683May 18 04:10 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerMay 16Sale18.411,11420,50970,492May 18 04:07 PM
Flammer Martina M.D.Chief Medical OfficerMay 16Sale18.511,57429,13566,432May 18 04:07 PM
Smith Michael AlexanderGeneral Counsel, Senior VPMay 16Sale18.484338,00251,638May 18 04:07 PM
SHAROKY MELVIN MDDirectorMay 11Buy17.2020,000344,000262,621May 13 06:15 PM
Lewis WilliamChair and CEOMar 23Option Exercise15.5696,6141,503,244283,029Mar 25 05:40 PM
Lewis WilliamChair and CEOMar 23Sale23.1696,6142,238,022217,624Mar 25 05:40 PM
Adsett RogerChief Operating OfficerJan 12Sale24.581,21729,914121,938Jan 13 04:41 PM
Bonstein SaraChief Financial OfficerJan 11Sale25.111,15428,97735,979Jan 13 04:41 PM
Flammer Martina M.D.Chief Medical OfficerJan 11Sale25.111,49537,53946,038Jan 13 04:41 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerJan 11Sale25.1192523,22756,961Jan 13 04:41 PM
Smith Michael AlexanderGeneral Counsel, Senior VPJan 11Sale25.1140710,22037,426Jan 13 04:41 PM
Lewis WilliamChair and CEOJan 11Sale25.112,87372,141217,624Jan 13 04:41 PM
Adsett RogerChief Operating OfficerJan 06Sale26.001,75945,734105,420Jan 07 04:28 PM
Smith Michael AlexanderGeneral Counsel, Senior VPJan 06Sale26.0038710,06228,375Jan 07 04:15 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerJan 06Sale26.001,61241,91248,428Jan 07 04:19 PM
Lewis WilliamChair and CEOJan 06Sale26.005,337138,762189,756Jan 07 04:25 PM
Lewis WilliamChair and CEOJan 05Sale27.617,126196,749195,093Jan 07 04:25 PM
Flammer Martina M.D.Chief Medical OfficerJan 05Sale27.611,42339,28933,345Jan 07 04:23 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerJan 05Sale27.611,50341,49850,040Jan 07 04:19 PM
Smith Michael AlexanderGeneral Counsel, Senior VPJan 05Sale27.6174920,68028,762Jan 07 04:15 PM
Adsett RogerChief Operating OfficerJan 05Sale27.613,06884,707107,179Jan 07 04:28 PM
Lewis WilliamChair and CEODec 27Option Exercise14.2446,614663,783248,833Dec 28 04:08 PM
Lewis WilliamChair and CEODec 27Sale27.7246,6141,292,140202,219Dec 28 04:08 PM
Lewis WilliamChair and CEODec 23Option Exercise13.5150,000675,296248,833Dec 28 04:08 PM
Lewis WilliamChair and CEODec 23Sale28.2150,0001,410,466202,219Dec 28 04:08 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerNov 01Option Exercise12.4461,000758,840112,514Nov 03 04:27 PM
ENGELSEN STEINAR JDirectorNov 01Buy30.1414,235429,043320,802Nov 03 04:26 PM
Brennan David RDirectorNov 01Buy30.1510,000301,50080,876Nov 03 04:27 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerNov 01Sale30.2861,0001,847,35251,514Nov 03 04:27 PM
Lewis WilliamChair and CEOSep 30Option Exercise3.4096,614328,488298,833Oct 01 04:10 PM
Lewis WilliamChair and CEOSep 30Sale27.3696,6142,643,753202,219Oct 01 04:10 PM
SORIANO JOHNChief Compliance OfficerSep 07Option Exercise13.9117,349241,32552,553Sep 09 04:10 PM
SORIANO JOHNChief Compliance OfficerSep 07Sale28.2017,349489,24235,204Sep 09 04:10 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do Not Sell My Data • Privacy Settings
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2022 FINVIZ.com. All Rights Reserved.